On 18 June 2024, Alzheimer Europe hosted a Company Round Table meeting in Luxembourg. The meeting was a hybrid event, with many participants attending in person and some joining remotely. It was attended by company representatives from Biogen, Danone (Nutricia), Eli Lilly, Novo Nordisk, Prothena Biosciences, Roche, Terumo Blood & Cell Technologies, members of the Alzheimer Europe staff and Board. During the meeting, seven Alzheimer Europe speakers provided updates on recent policy and research developments.
Cindy Birck (Project Officer) gave an update on our Clinical Trials Watch, an online database providing accessible and up-to-date information on clinical trials that are investigating drugs for Alzheimer’s disease and/or dementia. Owen Miller (Policy Officer) shared some updates on recent policy developments and on our European Parliament election campaign.
The next presentation was given by Angela Bradshaw (Director for Research) and Lukas Duffner (Project Officer), who updated the delegates on a project aiming to identify general public perceptions and expectations, and experiences of research participants, in the context of dementia research. Following a short break, a presentation on some of the EU projects in which Alzheimer Europe is a partner was delivered by Angela Bradshaw, Dianne Gove (Director for Public Involvement and Ethics) and Daphné Lamirel (Public Involvement Officer).
The meeting was moderated by Jean Georges (Executive Director) who also gave the final presentation of the meeting, informing participants about Alzheimer Europe’s activities in 2024 and the upcoming Annual Conference to be held from 8 to 10 October in Geneva, Switzerland, under the motto "New horizons – Innovating for dementia".
We would like to thank our sponsors and members for participating in this meeting and we look forward to welcoming them to the next Company Round Table meeting, which will take place online, on 18 September.